Search
for
Sort by
Research 811–840 of 1000+
- Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
- Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Poster Presentations
- Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature
- Myeloproliferative disorder associated with alopecia universalis
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- TREMendous Macrophages Inhibit Hair Growth
- Ruxolitinib found to cause eyelash growth: a case report
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Efficacy and Safety of Switching from Baricitinib to Ritlecitinib in Severe Alopecia Areata
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- USE OF UPADACITINIB IN 2 CASES OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- 455 Beyond Immunity: TEC and JAK3 Kinase Activation in Melanocytes Drives Inflammation in Vitiligo
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Tofacitinib in the Management of Alopecia Universalis
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Therapeutic Options to Refractory Alopecia Areata
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Targeted immunotherapy for hair regrowth and regeneration
- Therapeutic Response of Alopecia Areata‐Associated Nail Changes to Baricitinib
- Oclacitinib Treatment and Surgical Management in a Case of Periocular Eosinophilic Furunculosis and Vasculitis with Secondary Eyelid Fusion in a Diabetic Cat
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Deciphering the Complex Immunopathogenesis of Alopecia Areata